240 related articles for article (PubMed ID: 26689875)
1. Three faces of recombination activating gene 1 (RAG1) mutations.
Patiroglu T; Akar HH; Van Der Burg M
Acta Microbiol Immunol Hung; 2015 Dec; 62(4):393-401. PubMed ID: 26689875
[TBL] [Abstract][Full Text] [Related]
2. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.
Lee YN; Frugoni F; Dobbs K; Walter JE; Giliani S; Gennery AR; Al-Herz W; Haddad E; LeDeist F; Bleesing JH; Henderson LA; Pai SY; Nelson RP; El-Ghoneimy DH; El-Feky RA; Reda SM; Hossny E; Soler-Palacin P; Fuleihan RL; Patel NC; Massaad MJ; Geha RS; Puck JM; Palma P; Cancrini C; Chen K; Vihinen M; Alt FW; Notarangelo LD
J Allergy Clin Immunol; 2014 Apr; 133(4):1099-108. PubMed ID: 24290284
[TBL] [Abstract][Full Text] [Related]
3. Evolution of a T-B- SCID into an Omenn syndrome phenotype following parainfluenza 3 virus infection.
Dalal I; Tabori U; Bielorai B; Golan H; Rosenthal E; Amariglio N; Rechavi G; Toren A
Clin Immunol; 2005 Apr; 115(1):70-3. PubMed ID: 15870023
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia.
Alsmadi O; Al-Ghonaium A; Al-Muhsen S; Arnaout R; Al-Dhekri H; Al-Saud B; Al-Kayal F; Al-Saud H; Al-Mousa H
BMC Med Genet; 2009 Nov; 10():116. PubMed ID: 19912631
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic heterogeneity in Omenn syndrome and severe combined immune deficiency.
Gruber TA; Shah AJ; Hernandez M; Crooks GM; Abdel-Azim H; Gupta S; McKnight S; White D; Kapoor N; Kohn DB
Pediatr Transplant; 2009 Mar; 13(2):244-50. PubMed ID: 18822103
[TBL] [Abstract][Full Text] [Related]
6. Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency.
Kumaki S; Villa A; Asada H; Kawai S; Ohashi Y; Takahashi M; Hakozaki I; Nitanai E; Minegishi M; Tsuchiya S
Blood; 2001 Sep; 98(5):1464-8. PubMed ID: 11520796
[TBL] [Abstract][Full Text] [Related]
7. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.
Meshaal SS; El Hawary RE; Abd Elaziz DS; Eldash A; Alkady R; Lotfy S; Mauracher AA; Opitz L; Pachlopnik Schmid J; van der Burg M; Chou J; Galal NM; Boutros JA; Geha R; Elmarsafy AM
Clin Exp Immunol; 2019 Feb; 195(2):202-212. PubMed ID: 30307608
[TBL] [Abstract][Full Text] [Related]
8. Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome.
Bai X; Liu J; Zhang Z; Liu C; Zhang Y; Tang W; Dai R; Wu J; Tang X; Zhang Y; Ding Y; Jiang L; Zhao X
Immunol Res; 2016 Apr; 64(2):497-507. PubMed ID: 26476733
[TBL] [Abstract][Full Text] [Related]
9. Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.
Meshaal S; El Hawary R; Elsharkawy M; Mousa RK; Farid RJ; Abd Elaziz D; Alkady R; Galal N; Massaad MJ; Boutros J; Elmarsafy A
Clin Immunol; 2015 Jun; 158(2):167-73. PubMed ID: 25869295
[TBL] [Abstract][Full Text] [Related]
10. Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome.
van Til NP; Sarwari R; Visser TP; Hauer J; Lagresle-Peyrou C; van der Velden G; Malshetty V; Cortes P; Jollet A; Danos O; Cassani B; Zhang F; Thrasher AJ; Fontana E; Poliani PL; Cavazzana M; Verstegen MM; Villa A; Wagemaker G
J Allergy Clin Immunol; 2014 Apr; 133(4):1116-23. PubMed ID: 24332219
[TBL] [Abstract][Full Text] [Related]
11. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.
Wada T; Toma T; Okamoto H; Kasahara Y; Koizumi S; Agematsu K; Kimura H; Shimada A; Hayashi Y; Kato M; Yachie A
Blood; 2005 Sep; 106(6):2099-101. PubMed ID: 15845893
[TBL] [Abstract][Full Text] [Related]
12. Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies.
Brauer PM; Pessach IM; Clarke E; Rowe JH; Ott de Bruin L; Lee YN; Dominguez-Brauer C; Comeau AM; Awong G; Felgentreff K; Zhang YH; Bredemeyer A; Al-Herz W; Du L; Ververs F; Kennedy M; Giliani S; Keller G; Sleckman BP; Schatz DG; Bushman FD; Notarangelo LD; Zúñiga-Pflücker JC
Blood; 2016 Aug; 128(6):783-93. PubMed ID: 27301863
[TBL] [Abstract][Full Text] [Related]
13. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
[TBL] [Abstract][Full Text] [Related]
14. Lack of nonfunctional B-cell receptor rearrangements in a patient with normal B cell numbers despite partial RAG1 deficiency and atypical SCID/Omenn syndrome.
Ohm-Laursen L; Nielsen C; Fisker N; Lillevang ST; Barington T
J Clin Immunol; 2008 Sep; 28(5):588-92. PubMed ID: 18592361
[TBL] [Abstract][Full Text] [Related]
15. GvHD-associated cytokine polymorphisms do not associate with Omenn syndrome rather than T-B- SCID in patients with defects in RAG genes.
Haq IJ; Steinberg LJ; Hoenig M; van der Burg M; Villa A; Cant AJ; Middleton PG; Gennery AR
Clin Immunol; 2007 Aug; 124(2):165-9. PubMed ID: 17572155
[TBL] [Abstract][Full Text] [Related]
16. Late-onset combined immune deficiency associated to skin granuloma due to heterozygous compound mutations in RAG1 gene in a 14 years old male.
Sharapova SO; Migas A; Guryanova I; Aleshkevich S; Kletski S; Durandy A; Belevtsev M
Hum Immunol; 2013 Jan; 74(1):18-22. PubMed ID: 23085344
[TBL] [Abstract][Full Text] [Related]
17. Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or Omenn syndrome.
Dalal I; Tasher D; Somech R; Etzioni A; Garti BZ; Lev D; Cohen S; Somekh E; Leshinsky-Silver E
Clin Immunol; 2011 Sep; 140(3):284-90. PubMed ID: 21624848
[TBL] [Abstract][Full Text] [Related]
18. RAG1 reversion mosaicism in a patient with Omenn syndrome.
Crestani E; Choo S; Frugoni F; Lee YN; Richards S; Smart J; Notarangelo LD
J Clin Immunol; 2014 Jul; 34(5):551-4. PubMed ID: 24817258
[TBL] [Abstract][Full Text] [Related]
19. Novel RAG1 mutation and the occurrence of mycobacterial and Chromobacterium violaceum infections in a case of leaky SCID.
Khan TA; Iqbal A; Rahman H; Cabral-Marques O; Ishfaq M; Muhammad N
Microb Pathog; 2017 Aug; 109():114-119. PubMed ID: 28552805
[TBL] [Abstract][Full Text] [Related]
20. Human RAG mutations: biochemistry and clinical implications.
Notarangelo LD; Kim MS; Walter JE; Lee YN
Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
